GEC-ESTRO APBI: Toxicity at 5 years
APBI
WBI
Grade 2-3 late skin
3.23% 5.66% (ns)
Grade 2-3 subcutaneous fibrosis
7.59% 6.33% (ns)
Grade 2-3 breast pain
1.14% 3.17% (p = 0.04)
No grade 4 side effects at 5 years
Detailed analysis of late side-effects to be published seperately
Strnad V
et al
(2016) Lancet 387:229-238
Courtesy Chris Cottrill